---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-025613"
form_type: "8-K"
ticker: "CYCN"
cik: "0001755237"
company_name: "Cyclerion Therapeutics, Inc."
filed_at: "2022-11-22T23:59:59+00:00"
generated_at: "2026-06-21T14:13:34.043142+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cyclerion board rejects unsolicited CEO-led asset purchase proposal

## Summary
- Unsolicited proposal received Nov 20, 2022 from group including CEO to purchase certain assets.
- Independent board unanimously concluded proposal is not in the best interest of the Company.
- Board consulted legal and financial advisors prior to reaching its decision.
- Company will not make further statements on M&A activity unless deemed appropriate or necessary.

## SEC filing metadata
- accession: 0000950170-22-025613
- form_type: 8-K
- ticker: CYCN
- cik: 0001755237
- company_name: Cyclerion Therapeutics, Inc.
- filed_at: 2022-11-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1755237/000095017022025613/0000950170-22-025613-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1755237/000095017022025613/cycn-20221122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-025613
- JSON: https://secwatch.observer/filing/0000950170-22-025613.json
- Plain text: https://secwatch.observer/filing/0000950170-22-025613.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.